RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
RT @jardine_meg: As we start 2021, SGLT2i benefits for protecting people at risk of progressive kidney disease or heart failure appear just…
RT @NatRevNeph: Once again, SGLT2 inhibitors made the cut. In their #YearinReview, @jardine_meg and @AmyKang23 describe how the cardiac and…
RT @NatRevNeph: Once again, SGLT2 inhibitors made the cut. In their #YearinReview, @jardine_meg and @AmyKang23 describe how the cardiac and…
RT @NatRevNeph: Once again, SGLT2 inhibitors made the cut. In their #YearinReview, @jardine_meg and @AmyKang23 describe how the cardiac and…
RT @jardine_meg: As we start 2021, SGLT2i benefits for protecting people at risk of progressive kidney disease or heart failure appear just…
RT @jardine_meg: As we start 2021, SGLT2i benefits for protecting people at risk of progressive kidney disease or heart failure appear just…
RT @jardine_meg: As we start 2021, SGLT2i benefits for protecting people at risk of progressive kidney disease or heart failure appear just…
RT @jardine_meg: As we start 2021, SGLT2i benefits for protecting people at risk of progressive kidney disease or heart failure appear just…
RT @jardine_meg: As we start 2021, SGLT2i benefits for protecting people at risk of progressive kidney disease or heart failure appear just…
RT @jardine_meg: As we start 2021, SGLT2i benefits for protecting people at risk of progressive kidney disease or heart failure appear just…
RT @NatRevNeph: Once again, SGLT2 inhibitors made the cut. In their #YearinReview, @jardine_meg and @AmyKang23 describe how the cardiac and…
RT @jardine_meg: As we start 2021, SGLT2i benefits for protecting people at risk of progressive kidney disease or heart failure appear just…
RT @jardine_meg: As we start 2021, SGLT2i benefits for protecting people at risk of progressive kidney disease or heart failure appear just…
RT @jardine_meg: As we start 2021, SGLT2i benefits for protecting people at risk of progressive kidney disease or heart failure appear just…
As we start 2021, SGLT2i benefits for protecting people at risk of progressive kidney disease or heart failure appear just as strong in people without diabetes as in those with diabetes. More trials underway. In the meantime, we need to be thinking about i
RT @NatRevNeph: Once again, SGLT2 inhibitors made the cut. In their #YearinReview, @jardine_meg and @AmyKang23 describe how the cardiac and…
Once again, SGLT2 inhibitors made the cut. In their #YearinReview, @jardine_meg and @AmyKang23 describe how the cardiac and kidney benefits of #SGLT2 inhibitors extend beyond T2DM https://t.co/2P2TIJ3OoU https://t.co/7VeaWTPEJe
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
RT @edgarvlermamd: SGLT2 inhibitors: Diabetes and beyond 🚀 #Nephpearls 👉🏼 https://t.co/UcqNPkIN8i https://t.co/DpSngS4KCr
RT @edgarvlermamd: SGLT2 inhibitors: Diabetes and beyond 🚀 #Nephpearls 👉🏼 https://t.co/UcqNPkIN8i https://t.co/DpSngS4KCr
SGLT2i benefits in non diabetic kidney and heart failure
RT @rIvS_IvAn: Sin duda los SGLT2 sean convertido en piedra angular en el tratamiento de ERC e IC con y sin DM 😎♥️♥️♥️
RT @edgarvlermamd: SGLT2 inhibitors: Diabetes and beyond 🚀 #Nephpearls 👉🏼 https://t.co/UcqNPkIN8i https://t.co/DpSngS4KCr
RT @aishaikh: Benefits of SGLT2i on Kidney & Heart Failure outcomes in patients without Type 2 DM highlight the importance of its non-gluco…
RT @aishaikh: Benefits of SGLT2i on Kidney & Heart Failure outcomes in patients without Type 2 DM highlight the importance of its non-gluco…
RT @edgarvlermamd: SGLT2 inhibitors: Diabetes and beyond 🚀 #Nephpearls 👉🏼 https://t.co/UcqNPkIN8i https://t.co/DpSngS4KCr
RT @aishaikh: Benefits of SGLT2i on Kidney & Heart Failure outcomes in patients without Type 2 DM highlight the importance of its non-gluco…
RT @edgarvlermamd: SGLT2 inhibitors: Diabetes and beyond 🚀 #Nephpearls 👉🏼 https://t.co/UcqNPkIN8i https://t.co/DpSngS4KCr
RT @aishaikh: Benefits of SGLT2i on Kidney & Heart Failure outcomes in patients without Type 2 DM highlight the importance of its non-gluco…
RT @edgarvlermamd: SGLT2 inhibitors: Diabetes and beyond 🚀 #Nephpearls 👉🏼 https://t.co/UcqNPkIN8i https://t.co/DpSngS4KCr
RT @aishaikh: Benefits of SGLT2i on Kidney & Heart Failure outcomes in patients without Type 2 DM highlight the importance of its non-gluco…
Sin duda los SGLT2 sean convertido en piedra angular en el tratamiento de ERC e IC con y sin DM 😎♥️♥️♥️
RT @aishaikh: Benefits of SGLT2i on Kidney & Heart Failure outcomes in patients without Type 2 DM highlight the importance of its non-gluco…
Benefits of SGLT2i on Kidney & Heart Failure outcomes in patients without Type 2 DM highlight the importance of its non-glucose lowering effects. DAPA-HF, EMPEROR-Reduced & DAPA-CKD Trials included patients with & without DM https://t.co/1M1W
RT @edgarvlermamd: SGLT2 inhibitors: Diabetes and beyond 🚀 #Nephpearls 👉🏼 https://t.co/UcqNPkIN8i https://t.co/DpSngS4KCr
RT @edgarvlermamd: SGLT2 inhibitors: Diabetes and beyond 🚀 #Nephpearls 👉🏼 https://t.co/UcqNPkIN8i https://t.co/DpSngS4KCr
RT @edgarvlermamd: SGLT2 inhibitors: Diabetes and beyond 🚀 #Nephpearls 👉🏼 https://t.co/UcqNPkIN8i https://t.co/DpSngS4KCr
RT @edgarvlermamd: SGLT2 inhibitors: Diabetes and beyond 🚀 #Nephpearls 👉🏼 https://t.co/UcqNPkIN8i https://t.co/DpSngS4KCr
RT @edgarvlermamd: SGLT2 inhibitors: Diabetes and beyond 🚀 #Nephpearls 👉🏼 https://t.co/UcqNPkIN8i https://t.co/DpSngS4KCr
RT @edgarvlermamd: SGLT2 inhibitors: Diabetes and beyond 🚀 #Nephpearls 👉🏼 https://t.co/UcqNPkIN8i https://t.co/DpSngS4KCr
RT @edgarvlermamd: SGLT2 inhibitors: Diabetes and beyond 🚀 #Nephpearls 👉🏼 https://t.co/UcqNPkIN8i https://t.co/DpSngS4KCr
RT @edgarvlermamd: SGLT2 inhibitors: Diabetes and beyond 🚀 #Nephpearls 👉🏼 https://t.co/UcqNPkIN8i https://t.co/DpSngS4KCr
RT @edgarvlermamd: SGLT2 inhibitors: Diabetes and beyond 🚀 #Nephpearls 👉🏼 https://t.co/UcqNPkIN8i https://t.co/DpSngS4KCr
RT @edgarvlermamd: SGLT2 inhibitors: Diabetes and beyond 🚀 #Nephpearls 👉🏼 https://t.co/UcqNPkIN8i https://t.co/DpSngS4KCr
RT @edgarvlermamd: SGLT2 inhibitors: Diabetes and beyond 🚀 #Nephpearls 👉🏼 https://t.co/UcqNPkIN8i https://t.co/DpSngS4KCr
RT @edgarvlermamd: SGLT2 inhibitors: Diabetes and beyond 🚀 #Nephpearls 👉🏼 https://t.co/UcqNPkIN8i https://t.co/DpSngS4KCr
RT @edgarvlermamd: SGLT2 inhibitors: Diabetes and beyond 🚀 #Nephpearls 👉🏼 https://t.co/UcqNPkIN8i https://t.co/DpSngS4KCr
RT @edgarvlermamd: SGLT2 inhibitors: Diabetes and beyond 🚀 #Nephpearls 👉🏼 https://t.co/UcqNPkIN8i https://t.co/DpSngS4KCr
RT @edgarvlermamd: SGLT2 inhibitors: Diabetes and beyond 🚀 #Nephpearls 👉🏼 https://t.co/UcqNPkIN8i https://t.co/DpSngS4KCr
RT @edgarvlermamd: SGLT2 inhibitors: Diabetes and beyond 🚀 #Nephpearls 👉🏼 https://t.co/UcqNPkIN8i https://t.co/DpSngS4KCr
RT @edgarvlermamd: SGLT2 inhibitors: Diabetes and beyond 🚀 #Nephpearls 👉🏼 https://t.co/UcqNPkIN8i https://t.co/DpSngS4KCr
RT @edgarvlermamd: SGLT2 inhibitors: Diabetes and beyond 🚀 #Nephpearls 👉🏼 https://t.co/UcqNPkIN8i https://t.co/DpSngS4KCr
RT @edgarvlermamd: SGLT2 inhibitors: Diabetes and beyond 🚀 #Nephpearls 👉🏼 https://t.co/UcqNPkIN8i https://t.co/DpSngS4KCr
SGLT2 inhibitors: Diabetes and beyond 🚀 #Nephpearls 👉🏼 https://t.co/UcqNPkIN8i https://t.co/DpSngS4KCr
RT @paomorejon: 📌2020 el año de los iSGLT2 Preguntas por resolver: •El beneficio renal se mantiene en pacientes sin o con bajos niveles de…
RT @paomorejon: 📌2020 el año de los iSGLT2 Preguntas por resolver: •El beneficio renal se mantiene en pacientes sin o con bajos niveles de…
RT @paomorejon: 📌2020 el año de los iSGLT2 Preguntas por resolver: •El beneficio renal se mantiene en pacientes sin o con bajos niveles de…
RT @paomorejon: 📌2020 el año de los iSGLT2 Preguntas por resolver: •El beneficio renal se mantiene en pacientes sin o con bajos niveles de…
RT @paomorejon: 📌2020 el año de los iSGLT2 Preguntas por resolver: •El beneficio renal se mantiene en pacientes sin o con bajos niveles de…
RT @paomorejon: 📌2020 el año de los iSGLT2 Preguntas por resolver: •El beneficio renal se mantiene en pacientes sin o con bajos niveles de…
RT @paomorejon: 📌2020 el año de los iSGLT2 Preguntas por resolver: •El beneficio renal se mantiene en pacientes sin o con bajos niveles de…
RT @paomorejon: 📌2020 el año de los iSGLT2 Preguntas por resolver: •El beneficio renal se mantiene en pacientes sin o con bajos niveles de…
RT @paomorejon: 📌2020 el año de los iSGLT2 Preguntas por resolver: •El beneficio renal se mantiene en pacientes sin o con bajos niveles de…
RT @paomorejon: 📌2020 el año de los iSGLT2 Preguntas por resolver: •El beneficio renal se mantiene en pacientes sin o con bajos niveles de…
RT @paomorejon: 📌2020 el año de los iSGLT2 Preguntas por resolver: •El beneficio renal se mantiene en pacientes sin o con bajos niveles de…
RT @paomorejon: 📌2020 el año de los iSGLT2 Preguntas por resolver: •El beneficio renal se mantiene en pacientes sin o con bajos niveles de…
📌2020 el año de los iSGLT2 Preguntas por resolver: •El beneficio renal se mantiene en pacientes sin o con bajos niveles de albuminuria, con enfermedad glomerular o con marcada reducción de la función renal? •Beneficio en #HFpEF? #CardioEd https://t.co/
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
RT @staruschenko: SGLT2 inhibitors are clearly breakthrough in 2020. Great "Year-in-Review" commentary @NatRevNeph by @jardine_meg and @Amy…
RT @staruschenko: SGLT2 inhibitors are clearly breakthrough in 2020. Great "Year-in-Review" commentary @NatRevNeph by @jardine_meg and @Amy…
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
RT @staruschenko: SGLT2 inhibitors are clearly breakthrough in 2020. Great "Year-in-Review" commentary @NatRevNeph by @jardine_meg and @Amy…
RT @staruschenko: SGLT2 inhibitors are clearly breakthrough in 2020. Great "Year-in-Review" commentary @NatRevNeph by @jardine_meg and @Amy…
RT @staruschenko: SGLT2 inhibitors are clearly breakthrough in 2020. Great "Year-in-Review" commentary @NatRevNeph by @jardine_meg and @Amy…
SGLT2 inhibitors are clearly breakthrough in 2020. Great "Year-in-Review" commentary @NatRevNeph by @jardine_meg and @AmyKang23. In the same line as our editorial "SGLT2 inhibitors: diabetic kidney disease and beyond" @BhallaResearch @RangaswJ @AJPRenal ht
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…
RT @NatRevNeph: In our last 'Year-in-Review' of 2020 @jardine_meg and @AmyKang23 describe the cardiac and kidney benefits of #SGLT2 inhibit…